Search Results - Nina D. Wagner‐Johnston

Refine Results
  1. 1
    High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis

    High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis by Jori E. May, Kenneth R. Carson, Sara K. Butler, Weijian Liu, Nancy L. Bartlett, Nina D. Wagner‐Johnston

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

    Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS) by Nina D. Wagner‐Johnston, Brian K. Link, Michelle Byrtek, Keith Dawson, John D. Hainsworth, Christopher R. Flowers, Jonathan W. Friedberg, Nancy L. Bartlett

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients

    IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients by Jian He, Jian Wu, Yuchen Jiao, Nina D. Wagner‐Johnston, Richard F. Ambinder, Luis A. Díaz, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma

    AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma by Ariela Noy, Jeannette Y. Lee, Ethel Cesarman, Richard F. Ambinder, Robert A. Baiocchi, Erin Reid, Lee Ratner, Nina D. Wagner‐Johnston, Lawrence D. Kaplan

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A phase 2 study of inotuzumab ozogamicin in patients with indolent B‐cell non‐Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy

    A phase 2 study of inotuzumab ozogamicin in patients with indolent B‐cell non‐Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy by André Goy, Andres Forero, Nina D. Wagner‐Johnston, W. Christopher Ehmann, Michaela L. Tsai, Kiyohiko Hatake, Revathi Ananthakrishnan, Angela Volkert, Erik Vandendries, Michinori Ogura

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

    MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy by Collin Zimmerman, Philip J. Atherton, Deirdre R. Pachman, Drew K. Seisler, Nina D. Wagner‐Johnston, Shaker R. Dakhil, Jacqueline M. Lafky, Rui Qin, Axel Grothey, Charles L. Loprinzi

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

    Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide by Laura Schoch, Kenneth R. Cooke, Nina D. Wagner‐Johnston, Ivana Gojo, Lode J. Swinnen, Philip Imus, Ephraim J. Fuchs, Mark J. Levis, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)

    A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL) by Brad S. Kahl, Stephen E. Spurgeon, Richard R. Furman, Ian W. Flinn, Steven Coutré, Jennifer R. Brown, Don M. Benson, John C. Byrd, Sissy Peterman, Yoonjin Cho, Albert S. Yu, Wayne R. Godfrey, Nina D. Wagner‐Johnston

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

    Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance) by Deirdre R. Pachman, Rui Qin, Drew K. Seisler, Elizabeth Smith, Andreas S. Beutler, Lauren E. Ta, Jacqueline M. Lafky, Nina D. Wagner‐Johnston, Kathryn J. Ruddy, Shaker R. Dakhil, Nathan P. Staff, Axel Grothey, Charles L. Loprinzi

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

    A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma by Todd A. Fehniger, Sarah Larson, Kathryn Trinkaus, Marilyn J. Siegel, Amanda F. Cashen, Kristie A. Blum, Timothy S. Fenske, David D. Hurd, André Goy, Stephanie Schneider, Catherine R. Keppel, Nina D. Wagner‐Johnston, Kenneth R. Carson, Nancy L. Bartlett

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials

    Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 tri... by Sonali M. Smith, Brandelyn N. Pitcher, Sin‐Ho Jung, Nancy L. Bartlett, Nina D. Wagner‐Johnston, Steven Park, Kristy L. Richards, Amanda F. Cashen, Anthony J. Jaslowski, Scott E. Smith, Bruce D. Cheson, Eric D. Hsi, John P. Leonard

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL

    First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL by John C. Byrd, Stephen D. Smith, Nina D. Wagner‐Johnston, Jeff P. Sharman, Andy I. Chen, Ranjana H. Advani, Bradley Augustson, Paula Marlton, S. Renee Commerford, Kwame Okrah, Lichuan Liu, Elaine Murray, Elicia Penuel, Ashley F. Ward, Ian W. Flinn

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

    Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505) by Deirdre R. Pachman, Rui Qin, Drew K. Seisler, Elizabeth Smith, Suneetha Kaggal, Paul J. Novotny, Kathryn J. Ruddy, Jacqueline M. Lafky, Lauren E. Ta, Andreas S. Beutler, Nina D. Wagner‐Johnston, Nathan P. Staff, Axel Grothey, Patrick M. Dougherty, Guido Cavaletti, Charles L. Loprinzi

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

    Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update by Charles L. Loprinzi, Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Daniel L. Hertz, Mark R. Kelley, Antoinette Lavino, Maryam B. Lustberg, Judith A. Paice, Bryan P. Schneider, Elizabeth Smith, Mary Lou Smith, Thomas J. Smith, Nina D. Wagner‐Johnston, Dawn L. Hershman

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

    Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101 by Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina D. Wagner‐Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma

    Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma by Kenneth R. Carson, Peter A. Riedell, Ryan C. Lynch, Chadi Nabhan, Tanya M. Wildes, Weijian Liu, Arun Ganti, Ryan Roop, Kristen M. Sanfilippo, Katiuscia O’Brian, Jingxia Liu, Nancy L. Bartlett, Amanda F. Cashen, Nina D. Wagner‐Johnston, Todd A. Fehniger, Graham A. Colditz

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108

    Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108 by Paul M. Barr, Hongli Li, Catherine Spier, Daruka Mahadevan, Michael LeBlanc, Mansoor Ul Haq, Bryan D. Huber, Christopher R. Flowers, Nina D. Wagner‐Johnston, Steven M. Horwitz, Richard I. Fisher, Bruce D. Cheson, Sonali M. Smith, Brad S. Kahl, Nancy L. Bartlett, Jonathan W. Friedberg

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

    Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study by Gilles Salles, Stephen J. Schuster, Sven de Vos, Nina D. Wagner‐Johnston, Andreas Viardot, Kristie A. Blum, Christopher R. Flowers, Wojciech Jurczak, Ian W. Flinn, Brad S. Kahl, Peter Martin, Yeonhee Kim, Sanatan Shreay, Matthias Will, Bess Sorensen, Madlaina Breuleux, Pier Luigi Zinzani, Ajay K. Gopal

    Published 2016
    Get full text
    Carta
    Save to List
    Saved in:
  19. 19
    CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET

    CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET by David J. Straus, Sin‐Ho Jung, Brandelyn N. Pitcher, Lale Kostakoglu, J.C. Grecula, Eric D. Hsi, Heiko Schöder, Leslie Popplewell, Elizabeth Chang, Craig H. Moskowitz, Nina D. Wagner‐Johnston, John P. Leonard, Jonathan W. Friedberg, Brad S. Kahl, Bruce D. Cheson, Nancy L. Bartlett

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

    Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline by Dawn L. Hershman, Christina Lacchetti, Robert H. Dworkin, Elizabeth Smith, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Patrick G. Gavin, Antoinette Lavino, Maryam B. Lustberg, Judith A. Paice, Bryan P. Schneider, Mary Lou Smith, Thomas J. Smith, Shelby A. Terstriep, Nina D. Wagner‐Johnston, Kate Bak, Charles L. Loprinzi

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: